Rumors abound that we are seeing a covert gradual institutional exit, while those same institutions maintain and reiterate their price targets! Could they be THAT immoral? I don't think so.
The house will liquidate your positions for you when they are too far in the red. Pay up. Buy your shares back at a premium! You loathsome vermin are about to be vanquished.
The bankruptcy attorney. 0.7 log knockdown or greater! Rub your faces into that number! You shorts are being herded to the slaughter.
Sentiment: Strong Buy
It has been held commonly that the battle of Armageddon is an isolated event transpiring just prior to the second clinical trial for ARC520. The extent of this great movement in which God deals with "the shorts of the earth and of the whole world" (Rev. 16:14) will be seen as the final bankruptcy of the shorts in that the "battle of that great day of God Almighty" (Rev. 16:14) is not an isolated battle, but rather a campaign that extends over the last half of the period before the FDA approval of ACR520.
DVAX just enrolled phase III for HEPLISAV-B. it's a Hepatitis B vaccine that combines hepatitis B surface antigen with a cellular receptor site agonist to enhance the immune response. In other words, the vaccine forces the immune system awake. It does not address the proteins that suppress the immune system in the first place. Could that be why DVAX is trading at just over $1, while ARWR is trading for 15X as much?
The lack of transparency in the market place, here and overseas, is very frustrating. What set of circumstances would cause this to sell off almost a dollar and then recover it in one day? The only way to guess at that would be to see who was doing the selling and buying. Perhaps then you could get some kind of idea what their motives were, because this kind of price action makes zero sense on any kind of rational basis.
I suppose you might chalk up today based on the market action, a big buy by a major holder after it fell 5%, confirming his confidence in the company. Anyway, lacking any catalyst for movement until next month and into ASSLD. It seems we're likely to see more of this choppy movement. I don't see how you can trade it, there's no way to predict what it will do tomorrow. May as well flip a coin. Less
In J. R. R. Tolkien's fantasy writings, Orcs are a race of creatures who are used as soldiers and henchmen by both the greater and lesser villains of The Silmarillion and The Lord of the Rings — Morgoth, Sauron and Saruman.
Although not entirely dim-witted and occasionally crafty, they are portrayed as miserable beings, hating everyone including themselves and their masters, whom they serve out of fear. They make no beautiful things, but rather design cunning devices made to hurt and destroy. Very fitting for ORC. A destroyer of value. Cunning to draw people in and promise a monthly dividend.
I checked on that massive short position buildup. There has been no significant change in short interest.
With 80%institutional ownership and low float, the capacity for a surge in short interest doesn't exist. Unblinded data from phase II-A will be made public in about six weeks. After phase III is complete, ARWR will file ARC-520 with the FDA and bring it to the clinic.
Are you aware, little punk n16, that Arrowhead Research has the world lead with development of RNA interference therapy for Hepatitis-B virus? The drug has passed through the critical "derisking" phase. Financial institutions like Royal Bank of Canada (RBC), and Deutsche Bank of Germany know how much potential exists in Arrowhead Research Inc. Their price targets of $30 and $45 respectively are low-end conservative estimates and represent one year targets.
Sentiment: Strong Buy